共 116 条
[1]
Dunne E(2006)Genital human papillomavirus infection Clin Infect Dis 43 624-9
[2]
Markowitz L(2012)Economic burden of human papillomavirus-related diseases in Italy PLoS ONE 7 e49699-96
[3]
Baio G(2007)Cost-effectiveness analyses of human papillomavirus vaccination Lancet Infect Dis 7 289-74
[4]
Capone A(2011)Economic evaluation of human papilloma virus vaccination in the European Union: a critical review Intern Emerg Med 6 163-51
[5]
Marcellusi A(2009)Economic evaluation of human papillomavirus vaccination in developed countries Public Health Genomics 12 343-85
[6]
Mennini FS(2015)Extending the human papillomavirus vaccination programme to include males in high-income countries: a systematic review of the cost-effectiveness studies Clin Drug Investig 35 471-67
[7]
Favato G(2015)Public health value of universal HPV vaccination Crit Rev Oncol/Haematol 97 157-9
[8]
Newall TA(2014)Mind the gaps: what’s missing from current economic evaluations of universal HPV vaccination? Vaccine 32 3732-36
[9]
Beutels P(2015)PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation BMJ 349 g7647-312
[10]
Wood JG(2001)What is ecological validity? A dimensional analysis Infancy 2 419-31